Evidence map›Paper›PMID 22864808›Full record

ArticleGlycoconjugate journal2012

A novel model to predict O-glycosylation sites using a highly unbalanced dataset.

Kun Zhou, Chunzhi Ai, Peipei Dong, Xuran Fan, Ling Yang

Abstract read
PubMed Publisher
In one paragraph

Article in Glycoconjugate journal, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kun ZhouLaboratory of Pharmaceutical Resource Discovery, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, 457 Zhongshan Road, Dalian 116023, China.
Chunzhi Ai
Peipei Dong
Xuran Fan
Ling Yang

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In silico approaches have become an alternative method to study O-glycosylation. In this paper, we developed a linear interpretable model for O-glycosylation prediction based on an unbalanced dataset, analyzing the underlying biological knowledge of glycosylation. A training set of 4446 sites involving 468 positive sites and 3978 negative sites was developed during this research. The sites were encoded using the amino acid index (AAindex), and the forward stepwise procedure utilized for feature selection. The linear discriminant analysis with an equal a priori probability (PP-LDA) was employed to develop the interpretable model. Performance of the model was verified using both the internal leave-one-out cross-validation and external validation methods. Two non-linear algorithms, the supervised support vector machine and the unsupervised self-organizing competitive neural network, were used as comparisons. The PP-LDA model exhibited improved classification results with accuracy of 82.1% for cross-validations and 80.3% for external prediction. Further analysis of this linear model indicated that the properties at position R(1) and the properties relative to hydrophobicity contributed more to the glycosylation prediction. However, the alpha and turn propensities at the C-terminal, together with physicochemical properties at the N-terminal, are also relative to the glycosylation activity. This model is not only capable of predicting the possibility of glycosylation using an unbalanced dataset, but is also helpful to understand the underlying biological mechanisms of glycosylation. Considering the publicly accessibility of our prediction model, a downloadable program is provided in our supply materials.

Indexed as

Databases, ProteinModels, GeneticNeural Networks, ComputerSequence Analysis, ProteinSoftwareGlycoproteinsGlycosylationProtein Structure, TertiaryGlycoproteins

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.